MIRATI THERAPEUTICS INC's ticker is MRTX and the CUSIP is 60468T105. A total of 1 filers reported holding MIRATI THERAPEUTICS INC in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $12,119,394 | -10.2% | 278,223 | -25.5% | 0.14% | -11.2% |
| Q2 2023 | $13,488,485 | +36.3% | 373,332 | +40.3% | 0.16% | +18.5% |
| Q1 2023 | $9,893,598 | -65.7% | 266,100 | -58.2% | 0.14% | -65.0% |
| Q4 2022 | $28,849,647 | +85.6% | 636,717 | +186.2% | 0.39% | +77.9% |
| Q3 2022 | $15,540,000 | -21.1% | 222,508 | -24.2% | 0.22% | -28.6% |
| Q2 2022 | $19,707,000 | +90.1% | 293,567 | +132.9% | 0.30% | +81.0% |
| Q1 2022 | $10,364,000 | -43.4% | 126,048 | +0.9% | 0.17% | -35.9% |
| Q4 2021 | $18,320,000 | -8.5% | 124,892 | +10.4% | 0.26% | -19.9% |
| Q3 2021 | $20,016,000 | +31.4% | 113,143 | +20.0% | 0.33% | +15.1% |
| Q2 2021 | $15,228,000 | +185.8% | 94,276 | +203.1% | 0.28% | +140.7% |
| Q1 2021 | $5,328,000 | -9.8% | 31,103 | -39.9% | 0.12% | -49.6% |
| Q2 2020 | $5,907,000 | -23.9% | 51,742 | -48.7% | 0.23% | -57.8% |
| Q1 2020 | $7,760,000 | – | 100,953 | – | 0.55% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aviva Holdings Ltd. | 3,135,966 | $688,784,000 | 67.42% |
| Avoro Capital Advisors LLC | 4,535,000 | $996,067,000 | 17.15% |
| Darwin Global Management, Ltd. | 260,876 | $57,299,000 | 15.99% |
| Boxer Capital, LLC | 1,765,560 | $387,788,000 | 12.46% |
| Perceptive Advisors | 3,693,516 | $811,244,000 | 8.71% |
| Consonance Capital Management LP | 330,000 | $72,481,000 | 6.77% |
| EcoR1 Capital, LLC | 464,298 | $101,978,000 | 5.48% |
| Fairmount Funds Management LLC | 60,500 | $13,288,000 | 4.75% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 67,400 | $14,804,000 | 4.04% |
| RTW INVESTMENTS, LP | 1,054,364 | $231,581,000 | 3.88% |